Dimension Therapeutics, Inc. DMTX
Set alert
5.95 0.00 0.00%
At close · Jun 28
5.95 Day range 6.00
1.05 52-week range 6.10
- Open
- 5.98
- Prev close
- 5.95
- Mkt cap
- 0
- Vol
- 27.70K
- Avg vol
- 140.77K
- EPS
- -2.23
- P/E
- -2.67
- Div yield
- 0.00%
More statistics
- Low
- 5.95
- High
- 6.00
- Forward P/E
- -2.70
- Beta
- 0.00
- Short ratio
- 4.13
- Inst. own
- 71.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2017
- 50-d avg
- 25.72
- 200-d avg
- 8.79
- 1y target
- 6.00
Analyst view
Consensus: hold
Hold
Price target (mean) 6.00
Recommendation trend
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.48 | -0.48 – -0.48 | -0.53 | +9.4% | 4.30M | +4.1% | 1 |
| Next quarter | -0.56 | -0.56 – -0.56 | -0.54 | -3.7% | 3.30M | -8.8% | 1 |
| Current year | -1.99 | -1.99 – -1.99 | -1.97 | -1.0% | 14.60M | +27.3% | 1 |
| Next year | -2.20 | -2.20 – -2.20 | -1.99 | -10.6% | 13.50M | -7.5% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2017 | Wells Fargo | Downgrade | Outperform | Market Perform |
| Oct 2, 2017 | Citigroup | Upgrade | Sell | Neutral |
| Sep 18, 2017 | Citigroup | Downgrade | Neutral | Sell |
| Aug 29, 2017 | Canaccord Genuity | Downgrade | Buy | Hold |
| May 11, 2017 | Citigroup | Downgrade | — | Neutral |
| Jan 31, 2017 | Cantor Fitzgerald | Downgrade | — | Neutral |
| Jun 1, 2016 | Jefferies | Initiated | — | Buy |
| Mar 29, 2016 | Goldman Sachs | Downgrade | — | Neutral |
| Feb 17, 2016 | Cantor Fitzgerald | Initiated | — | Buy |
| Dec 3, 2015 | Wells Fargo | Initiated | — | Outperform |
| Dec 3, 2015 | Goldman Sachs | Initiated | — | Buy |
| Nov 15, 2015 | Citigroup | Initiated | — | Buy |
| Nov 15, 2015 | Canaccord Genuity | Initiated | — | Buy |
| Nov 15, 2015 | Goldman Sachs | Initiated | — | Buy |
| Nov 5, 2015 | Roth Capital | Initiated | — | Buy |